HomeAI · summaries
Storia in 7 fonti
FDA authorizes marketing of risk modification claim on Zyn nicotine pouches
The FDA has authorized marketing of a risk modification claim on 20 Zyn nicotine pouch products that were authorized for sale in the U.S. last year.According to an FDA press release, marketing of these products can now include the modified risk claim that “using Zyn instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
FDA authorizes marketing of risk modification claim on Zyn nicotine pouches
The FDA has authorized marketing of a risk modification claim on 20 Zyn nicotine pouch products that were authorized for sale in the U.S. last year.According to an FDA press…
- ·
cnbc.com
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes
The Trump administration has expanded access to nicotine products despite concerns from public health critics about youth use and addiction.
